top of page

Reviva to Present at the 36th Annual ROTH Conference

CUPERTINO, Calif., March 07, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 36th Annual ROTH Conference, taking place March 17-19, 2024, in Dana Point, CA. Reviva to Present at the 36th Annual ROTH Conference

Aktuelle Beiträge

Alle ansehen

Kommentare


bottom of page